Description
BeyoRT™ II First Strand cDNA Synthesis Kit with gDNA Eraser provides all the reagents needed for the synthesis of first-strand cDNA except RNA template (total RNA or mRNA). It employs the optimized BeyoRT™ II M-MLV reverse transcriptase (RNase H-) for the reverse transcription. The first-strand cDNA synthesized with this kit can be directly used for subsequent PCR, real-time qPCR, second-strand cDNA synthesis, and construction of cDNA libraries, etc.
The gDNA Eraser provided in this kit can effectively remove genomic DNA (gDNA) contamination from RNA samples to avoid the interference with the subsequent qPCR and simplifies the qPCR primer design by eliminating the need for cross-intron primers. Adding gDNA Eraser to RNA samples followed by incubation at 37℃ for 2 minutes can effectively remove gDNA contaminations. RNA samples treated with gDNA Eraser can be directly used for reverse transcription because the Reverse Transcription Buffer (RT Buffer) supplied in this kit contains substance that inhibits gDNA Eraser. The cDNA product can also be directly used for subsequent conventional PCR or qPCR as gDNA Eraser will be inactivated under the denaturation condition of PCR.
This kit utilizes the BeyoRT™ II M-MLV reverse transcriptase (RNase H-), with high reverse transcription efficiency, good thermal stability, and the capability of synthesizing long cDNA products. It has an optimum working temperature at 42-45℃, but is still highly active at temperatures up to 50℃.
When a reaction volume of 20μl is used, D7170S, D7170M and D7170L are sufficient for 20, 100 and 500 reactions, respectively.
Packing List:
| Item |
Component |
Quantity |
| D7170M-1 |
5X gDNA Eraser Buffer |
200μl |
| D7170M-2 |
5X RT Buffer |
400μl |
| D7170M-3 |
BeyoRT™ II M-MLV Reverse transcriptase (RNase H-) |
200μl |
| D7170M-4 |
10X RT Primer Mix |
200μl |
| D7170M-5 |
DEPC-treated Water |
1.5ml |
| Manual |
– |
1 copy |
Storage Conditions:
Store kit at -20℃ upon receipt.
Precautions:
Please refer to the instructions for reverse transcription of RNAs with high GC content.
This product is for R&D only. Not for drug, household, or other uses.
For your safety and health, please wear a lab coat and disposable gloves during the operation.
Instruction
Instructions for Use:
1. Removal of genomic DNA from RNA samples
a. Thaw RNA samples and 5X gDNA Eraser Buffer on ice. Thaw 5X RT Buffer, 10X RT Primer Mix, and DEPC-treated Water at room temperature (15-25℃), and immediately place on ice after melting. Mix each solution well prior to use and centrifuge briefly to collect the liquid at the bottom of the tube.
b. RNA denaturation (optional): heat RNA samples at 65℃ for 5 minutes and immediately place on ice, which can effectively improve the reverse transcription of RNAs with secondary structures.
Note: Do not add the gDNA Eraser Buffer at this step.
c. Set up the following reaction on ice. To ensure the accuracy, prepare an appropriate amount of master mix (except RNA) based on the number of reactions, and then dispense into each tube before adding RNA.
| Reagent |
Quantity |
| 5X gDNA Eraser Buffer |
2μl |
| Total RNA |
up to 1μg* |
| DEPC-treated Water |
To 10μl |
| Total volume |
10μl |
*A 20μl reverse transcription reaction requires 10pg to 1μg of Total RNA, and we recommend using 0.5-1μg of Total RNA.
d. Incubate at 37℃ for 2 min on a thermocycler or in a water bath. Then Immediately place the reaction mixture on ice.
2. First-strand cDNA synthesis
a. Referring to the following table, prepare an appropriate amount of 2X Master Mix based on the number of reactions. If the reverse transcription experiment is frequently performed, a mix of 5X RT Buffer and 10X RT Primer Mix at 2:1 can be prepared for frequent use.
| Reagent |
Quantity |
| 5X RT Buffer* |
4μl |
| 10X RT Primer Mix** |
2µl |
| BeyoRT™ II M-MLV Reverse transcriptase (RNase H-)*** |
2μl |
| DEPC-treated water |
2μl |
| Total volume (2X Master Mix) |
10μl |
* Containing Mg2+ and dNTP
** The mixture of Oligo dT Primer and Random Hexamers
*** Containing RNase Inhibitor
b. Dispense 10μl of the 2X Master Mix into each reaction tube obtained in step 1 and mixed thoroughly.
c. Incubate at 42℃ for 60 min, followed by 10 min at 80℃ to inactivate the reverse transcriptase. Keep the reaction products on ice.
Note: For RNAs with complex secondary structures or high GC content, the reverse transcription temperature can be increased to 50℃ to improve the reverse transcription efficiency.
d. The cDNA products can be used immediately or stored at -20℃ for subsequent experiments such as qPCR and conventional PCR. For long-term storage, it is recommended to store the cDNA at -80℃ in aliquots.
FAQ:
1. The reverse transcription product of total RNA is invisible after electrophoresis.
It is a normal phenomenon, because the amount of RNA template is low, and the amount of reverse transcription products in different size is even lower.
2. No specific product can be amplified from the reverse transcription product, or there is no or delayed signal in qPCR.
a. To exclude the problem of PCR reaction system or reverse transcription product, use gene-specific primers to amplify internal reference genes, such as actin and GAPDH. If reference genes can be amplified, but not the target gene, it indicates primers of target gene are not well designed, the expression of the target gene is too low to be detected, or the reverse transcription efficiency is low.
b. Template RNA may be degraded. The integrity of total RNA can be checked by agarose gel or on-chip electrophoresis. Intact total RNA exhibits sharp, clear 28S and 18S rRNA bands, and the 28S rRNA band should be approximately twice as intense as the 18S rRNA band. A ratio less than 2 indicates the degradation of total RNA and new total RNA should be prepared.
c. RNA samples may contain some components that inhibit the activity of reverse transcriptase. Those contaminants include phenol, SDS, EDTA, guanidine salts, phosphoric acid, pyrophosphoric acid, polyamine, spermidine, etc, which can be removed effectively by column purification or precipitation, washing, and redissolution. Total RNA extracted by BeyoZol (R0011) or Trizol (R0016) usually can meet the requirements of reverse transcription.
d. Insufficient templates for reverse transcription. When DNase I used to remove the residual DNA in RNA sample prior to reverse transcription is subjected to heat-inactivation, EDTA should be added to RNA sample at a final concentration of 2.5mM to protect RNA from degradation under high temperatures. Additionally, to amplify a specific gene, it is necessary to extract RNA from tissues in which the target gene is highly expressed.
e. Inappropriate primer is used for reverse transcription. Random hexamer instead of Oligo(dT)18 should be used for the reverse transcription of bacterial total RNA which does not have poly(A) tails. Gene-specific primers used for reverse transcription must be well designed.
a. The lack of signal or delayed signal in qPCR may be due to the addition of too much reverse transcription product, which will interfere with the PCR reactions. The volume of reverse transcription products added to PCR reactions should be less than 10% of the total volume of PCR reactions, and even less for qPCR reactions.
References
Related papers:
1. Fenbo M, Xingyu X, Bin T
.
CARBOHYD POLYM. 2019 Jun 1 213:266-275. (IF 7.182)
2. Deng Y, Ma F, Ruiz-Ortega LI, Peng Y, Tian Y, He W, Tang B
.
Int J Biol Macromol. 2019 Nov 1 140:727-735. (IF 5.162)
3. Zhang ZZ, Zhang HZ, Zhang ZY
.
Exp Ther Med. 2019 Jan 17(1):79-90. (IF 1.785)
4. Peng Y, Xing SN, Tang HY, Wang CD, Yi FP, Liu GL, Wu XM
.
Gene. 2019 Mar 20 689:11-17. (IF 2.984)
5. Gu Y, Zhang J, Zhang X, Liang G, Xu T, Niu W
.
Tissue Eng Regen Med. 2019 Jun 17 16(4):415-429. (IF 2.374)
6. Zhi-Yun Liu, Chun-Guang Zhao
.
Chin Med J (Engl). 2021 Dec 8;134(24):2999-3008. doi: 10.1097/CM9.0000000000001563.
7. Jingjing Lu, Bingqi Zhu, Fangmei Zhou, Xinghong Ding, Chaodong Qian, Zhishan Ding, Xiaoqing Ye
.
Front Pharmacol. 2022 Mar 11:13:838873. doi: 10.3389/fphar.2022.838873. (IF 4.225)
8. Panfeng Chen, Xiaoping Li, Xi Yu, Min Yang
.
Evid Based Complement Alternat Med. 2022 Jul 1:2022:1244836. doi: 10.1155/2022/1244836.
9. Wendan He, Xianlong Xie, Chenxi Li, Huang Ding, Jishi Ye
.
Molecules. 2022 Sep 23;27(19):6267. doi: 10.3390/molecules27196267. (IF 3.267)
10. Meng Yu, Weiyan Wang, Jingye Dang, Binghua Liu, Junling Xu, Jingjing Li, Yang Liu, Libo He, Yuling Ying, Jiaxiu Cai, Guohua Cheng, Ke Liu
.
Exp Cell Res. 2023 Jan 1;422(1):113436. doi: 10.1016/j.yexcr.2022.113436. (IF 3.383)
11. Hongya Gan, Bingqi Zhu, Fangmei Zhou, Zhishan Ding, Jing Liu, Xiaoqing Ye
.
Environ Sci Pollut Res Int. 2023 Jan;30(2):2665-2675. doi: 10.1007/s11356-022-22328-x.
12. Xinyue Yang, Depeng Li, Meihong Zhang, Yuqing Feng, Xiaolu Jin, Dan Liu, Yuming Guo, Yongfei Hu
.
J Anim Sci Biotechnol. 2023 Aug 3;14(1):97. doi: 10.1186/s40104-023-00900-w.
13. Lin Lin, Kuimiao Deng, Zongrong Gong, Huifeng Fan, Dongwei Zhang, Gen Lu
.
ACS Omega. 2023 Sep 7;8(37):33514-33525. doi: 10.1021/acsomega.3c03319.
14. Xin Yao, Linhan Zhong, Mengmeng Wang, Mei Wang, Yanyan Han, Yixin Wang, Jiaying Zhou, Jingge Song, Yuan Li, Yigang Xu
.
Int J Biol Macromol. 2023 Dec 31;253(Pt 7):127351. doi: 10.1016/j.ijbiomac.2023.127351.